0% Complete
صفحه اصلی
/
4th international edition and 13th Iranian Conference on Bioinformatics
Comprehensive Computational Strategies for Multi-Target Drug Discovery in Inflammatory Bowel Disease Utilizing Bioactive Compounds
نویسندگان :
Pardis Mansouri
1
Pegah Mansouri
2
Sohrab Najafipour
3
Seyed Amin Kouhpayeh
4
Akbar Farjadfar
5
Esmaeil Behmard
6
1- Fasa University of Medical Sciences
2- Fasa University of Medical Sciences
3- Fasa University of Medical Sciences
4- Fasa University of Medical Sciences
5- Fasa University of Medical Sciences
6- Fasa University of Medical Sciences
کلمات کلیدی :
Inflammation،Inflammatory bowel disease،Anti-inflammation،Multi-Target Drugs
چکیده :
Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease that includes ulcerative colitis and Crohn's disease. Based on the pathogenesis of the disease, simultaneously targeting inflammation and the epithelial barrier could have an effective role in improving the symptoms of this disease. Previously, each of these therapeutic targets, PDE4, PHD1, and PHD2, has been investigated separately. But finding small molecules that can inhibit multi-targets is so essential for treating diseases with multi-pathways like IBD. The enzyme phosphodiesterase 4 (PDE4) plays an important role in inflammation. PDE4 is involved in the production of inflammatory cytokines by converting cAMP to AMP. Inhibition of this enzyme leads to inhibition of inflammatory cytokine production and the production of anti-inflammatory cytokines. Also, It is demonstrated that inhibition of prolyl hydroxylase domain enzymes 1⁄2 (PHD1/2) increases HIF-a levels and improves the epithelial barrier following the expression of protective factors such as mucin and β-defensin. Therefore, inhibition of PDE4B and PHD1/2 can be a potential therapeutic target for the treatment of IBD and the improvement of pathological symptoms in it. In this study, after Virtual Screening, Molecular Docking, and Molecular Dynamics, our results introduced 5 compounds including Cassiamin C, Ginkgetin, Hinokiflavone, Sciadopitysin, and Sojagol as new drug candidates for the treatment of IBD. All compounds inhibit all three targets more effectively than the reference ligands, except for Sojagol, which shows lower activity against PDE4B. Future experimental studies can validate these findings.
لیست مقالات
لیست مقالات بایگانی شده
Targeting Protein in Neurodegenerative Diseases: A Computational Approach
Reyhaneh Ebrahimi - Seyed Hassan Alavi - Fayaz Soleymani - Fatemeh Zare-Mirakabad
Integrating Biological Networks and Deep Learning for Microbe-Disease Prediction
Sobhan Ahmadian Moghadam - Zahra Ghorbanali - Fatemeh Zare-Mirakabad - Hesam Montazeri
Exploring the anti-inflammatory potential of the silymarin against IL-17A: in silico molecular docking
Tooba Abdizadeh
In-silico investigation of bioactive peptides with anti-Alzheimer potential derived from bovine milk αs1-casein protein
Mohammad Jahangiri - Leila Zarandi-Miandoab
Identification of key genes associated with glioblastoma multiforme using microarray data
Motahareh Shanyan - Sohrab Boozarpour - Zahra Pezeshkian - Hossain Sabori - Mahmoud Salehi
Inhibition of angiogenesis based on the dynamic model of tumor growth using adaptive control method
Mehdi Ghasemi - Adel Akbarimajd - Solmaz Kia
Molecular Docking Study of Pyrazole Interaction with Bovine Serum Albumin (BSA): Insights from Drug-Protein Binding
Parisa Zallou - Yaghub Pazhang - Ebrahim Nemati-Kande
Novel Anti-ageing Strategy Via Targeting CST With Vitamin B1
SeyedMobin Mousavi Ghomi - Maryam Azimzadeh Irani - Aida Arezoumandchafi
Exploring the Antibiotic Potential of Micromonospora
Niloufar Zamanpour - Najmeh Salehi - Javad Hamedi
Exploring Genetic Variability: A Bioinformatics Approach to Analyzing Reported SNPs in the cagA Gene of Helicobacter pylori
Aria Soltani
بیشتر
ثمین همایش، سامانه مدیریت کنفرانس ها و جشنواره ها - نگارش 42.7.0